PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
5.31
P/E near Medical - Pharmaceuticals median of 5.29. Peter Lynch would check if company growth exceeds Medical - Pharmaceuticals average to justify this multiple.
0.57
P/S less than half the Medical - Pharmaceuticals median of 5.34. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
1.19
P/B 50-90% of Medical - Pharmaceuticals median of 1.46. Mohnish Pabrai would examine if this discount presents opportunity.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.19
Fair value ratio 50-90% of Medical - Pharmaceuticals median of 1.46. Mohnish Pabrai would examine if this gap presents opportunity.
4.71%
Earnings yield exceeding 1.5x Medical - Pharmaceuticals median of 1.09%. Joel Greenblatt would investigate if high yield reflects hidden value.
No Data
No Data available this quarter, please select a different quarter.